Is seeing a specialist nurse associated with positive experiences of care? The role and value of specialist nurses in prostate cancer care
Carolyn Tarrant*1, Paul Sinfield2, Shona Agarwal2 and Richard Baker2
Address:
Sciences, University of Leicester, 22-28 Princess Road West, Leicester, LE1 6TP, UK
Email: Carolyn Tarrant* - ccp3@le.ac.uk; Paul Sinfield - pks4@le.ac.uk; Shona Agarwal - sa144@le.ac.uk; Richard Baker - rb14@le.ac.uk
* Corresponding author1Department of Health Sciences, University of Leicester, 2nd Floor, Adrian Building, Leicester, LE1 7RH, UK and 2Department of Health
Abstract
Background:
of patients with prostate cancer, however there is concern that the specialist nurse role is under
threat in the UK due to financial pressures in the NHS. This study explored the role and value of
specialist nurses in prostate cancer care via a survey and patient interviews.Specialist nurses may play an important role in helping to improve the experiences
Methods:
across the UK (289/481, 60%), investigated whether patients who saw a specialist nurse had
different experiences of information provision and involvement in decision-making, to those who
did not. Qualitative interviews were also carried out with 35 men recently tested or treated for
prostate cancer, recruited from two hospitals in the UK. Interviews explored patients' views on
the role and value of the specialist nurse.This paper reports findings from two studies. A survey of patients from three hospitals
Results:
experiences of receiving written information about tests and treatment, and about sources of
advice and support, and were more likely to say they made the treatment decision themselves. In
interviews, patients described specialist nurse input in their care in terms of providing information
and support immediately post-diagnosis, as well as being involved in ongoing care. Two key aspects
of the specialist nurse role were seen as unique: their availability to the patient, and their ability to
liaise between the patient and the medical system.Survey findings indicated that patients who saw a specialist nurse had more positive
Conclusion:
patients with prostate cancer, and highlights the importance of maintaining specialist nurse roles in
prostate cancer care.This study indicates the unique role that specialist nurses play in the experience of
Background
The care that cancer patients in the UK receive has been
under scrutiny, and patients with prostate cancer have
been found to report less positive experiences of care than
patients with other types of cancer. Patients with prostate
cancer are less likely to have the opportunity to discuss
side effects of treatment, to understand how well their
treatment has gone, or to get information about support
and self help groups, than patients with other types of
cancer [1].
Published: 27 March 2008
BMC Health Services Research
Received: 24 August 2007
Accepted: 27 March 2008
This article is available from: http://www.biomedcentral.com/1472-6963/8/65
© 2008 Tarrant et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.2008, 8:65 doi:10.1186/1472-6963-8-65
BMC Health Services Research
Page 2 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
(page number not for citation purposes)
The role of the specialist nurse in prostate cancer care can
be varied, but is primarily focused on the provision of
information and support to patients [2]. Specialist nurse
involvement may help to improve the experiences of
patients with prostate cancer, and may be associated with
positive outcomes [3-5]. The NICE Improving Outcomes
Guidance on urological cancers emphasised the importance
of specialist nurses in prostate cancer care [6], however,
prostate cancer patients have lower levels of access to
specialist nurses than do patients with other types of cancer
[1]. Individuals and organizations involved in prostate
cancer care have pointed to the availability of specialist
nurses as a key priority for government action [7].
Set against this, current financial pressures in the NHS are
threatening specialist nurse posts, with specialist nurses
expressing concern that they may face losing their jobs, or
may have to give up some or all of their time in their specialist
role to work as generalist nurses on hospital wards
in order to cover staffing shortages [8-10]. The role of specialist
nurses in dealing with information, advice and
emotional support, may appear to be "less tangible and a
relative 'luxury' when compared with ward-based nurses"
[11], leading to their roles being reviewed when resources
are constrained. However, Richardson [12] has identified
that patients with prostate cancer are more likely to report
unmet needs if they do not see a specialist nurse.
There is a need for further research into the role and value
of specialist nurses in prostate cancer care, to support decisions
about the importance of maintaining and increasing
the availability of specialist nurses to patients with prostate
cancer.
This paper reports findings from two linked studies carried
out as part of a larger study to develop a measure of
patient experience of prostate cancer care [13]. A questionnaire
survey of patients' experiences of prostate cancer
care provided an opportunity to investigate whether
patients who saw a specialist nurse had more positive
experiences of care than those who did not. Qualitative
interviews with patients and carers further explored
patient perceptions of the role and value of the specialist
nurse in prostate cancer care.
Methods
Two methodological approaches were used: a quantitative
patient survey and a qualitative investigation of patients'
experiences.
A questionnaire on experiences of prostate cancer care was
mailed to a sample of 481 patients who had been tested
or treated for prostate cancer during the previous two
years at one of three hospitals in different regions of the
UK. Patients were randomly selected from clinic lists for
several clinics at each hospital, including patients who
were undergoing different types of treatment, and were at
different stages in their care. There were no age restrictions
put on the sample. Clinic staff were asked to check the lists
and exclude any patients who had not been diagnosed, or
who were not aware of their diagnosis.
The questionnaire was developed as part of the larger
study, and was based on themes identified through interviews
of patients with prostate cancer and health professionals
[13]. The questionnaire included a question about
whether the patient had seen a specialist nurse following
their diagnosis. It also included a number of questions
relating to the provision of information about treatment
options, patient involvement in the treatment decision,
and the provision of information about sources of advice
and support. Univariate analysis (ANOVA) was used to
identify whether patients who saw a specialist nurse had
different experiences of these issues to patients who did
not see a specialist nurse.
In order to further explore the role of the specialist nurse
in prostate cancer care, an analysis of patient interviews
undertaken as part of the larger study [13] was also carried
out. Interviews were with prostate cancer patients from
two hospitals in the East Midlands, UK, recruited using a
quota sampling frame to ensure that patients at different
stages of disease and treatment, and in different age and
ethnicity groups, were included. Patients were identified
from attendees at Urology Clinics and from hospitals'
patient registers. In addition, two cancer charities were
asked to contact patients from ethnic minority groups to
ensure that both South Asians and Afro-Caribbeans were
represented in the sample.
The interviews were semi-structured and aimed to explore
patients' experiences over the course of their care, including
initial GP visit(s), further testing, diagnosis, treatment,
and ongoing monitoring (where relevant). The interviews
did not specifically aim to explore the role of the specialist
nurse, although the role and value of the specialist nurse
emerged as a theme. Interviews were carried out in
patients' own homes; in some cases, the patient's wife or
partner was present and also participated in the interview.
The interviews were audiotaped and transcribed verbatim,
then transferred into the software package NUD*IST 6,
and analysed using the Framework approach [14]. Analysis
was undertaken to specifically explore the role and
value of the specialist nurse in patients' experiences of
prostate cancer care. All quotes used have been anonymised,
and a patient identification number is given in
brackets at the end of each quote.
BMC Health Services Research
Page 3 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
(page number not for citation purposes)
Results
Participants
The questionnaire was completed by 289 patients (60%).
Of these, 252 (87.2%) had seen a specialist nurse, and 37
(12.8%) had not. The characteristics of survey responders
are given in Table 1. Patients who did not see a specialist
nurse were more likely to be in the 75+ age group than
patients who did see a specialist nurse (
0.001), but did not differ significantly in terms of ethnicity,
health status, treatment type, or time since most recent
treatment.
Qualitative interviews were carried out with 35 patients;
in 10 of the interviews the wife/partner was also present.
The characteristics of the patients interviewed are given in
Table 2.F = 8.20; p <
Findings – questionnaire survey
Results from the questionnaire survey were analysed to
explore whether patients who saw a specialist nurse had
different experiences of care to patients who did not see a
specialist nurse. Table 3 shows the odds ratios for questions
on patient experience of care, comparing patients
who did see a specialist nurse with those who did not,
adjusted to take patient age into account. An odds ratio
greater than one indicates that a positive response to the
question was more likely in the first group (who did see a
specialist nurse) than in the second group (who did not
see a specialist nurse).
Patients who saw a specialist nurse were significantly
more likely to say that they were given enough written or
printed information about their test results and treatment
options (Table 3, questions 1, 2, 3, 7 and 8). They were
also more likely to feel that their treatment options were
clearly explained (Table 3, question 4). Patients who saw
a specialist nurse were much more likely to report that
they had been given enough information about sources of
help (Table 3, question 13). There were no significant differences
in terms of whether side effects of treatment were
clearly discussed, or whether the doctor or nurse discussed
with them why other treatment options were not suitable
(Table 3, questions 5 and 6).
Patients who saw a specialist nurse were more likely to say
that they made the treatment decision themselves (Table
3, question 9), although there was no significant difference
between the groups in the extent to which they felt
involved in the treatment decision. Patients who saw a
specialist nurse were more likely to have been told that
they could discuss the treatment decision again, and could
change their mind about treatment (Table 3, questions 11
and 12).
Findings – qualitative interviews
The analysis of the qualitative interviews explored the role
of the specialist nurse in prostate cancer care, with the aim
of understanding the differences in experiences of patients
who did and did not see a specialist nurse, and the perceived
value of the specialist nurse role.
Role of the specialist nurse in patients' experiences of prostate
cancer care
Most patients first saw the specialist nurse after being
given their diagnosis by a consultant. At this stage patients
often had to contemplate their diagnosis, consider a range
of treatment options, and make a treatment decision.
Here the role of the specialist nurse involved providing
time for the patient to talk about the diagnosis and ask
questions, and providing information about the diagnosis,
treatment options, and support services.
Table 1: Characteristics of questionnaire survey responders (n = 289)
Saw specialist nurse
number (%)
Did not see specialist
nurse number (%)
Total number (%)
Age
55–64 83 (32.9) 7 (18.9) 90 (31.1)
65–74 121 (48.0) 14 (37.8) 135 (46.7)
75 or over 29 (11.5) 16 (43.2) 45 (15.6)up to 54 6 (2.4) 0 6 (2.1)
Ethnicity
South Asian 5 (2.0) 2 (5.4) 7 (2.4)
African/Caribbean 21 (8.3) 0 21 (7.3)
Other 1 (0.4) 0 1 (0.3)White 211 (83.7) 35 (94.9) 246 (85.1)
Stage of disease/
treatment
Newly diagnosed (not yet
treated)
0 0 0
Being actively monitored without
treatment
38 (15.1) 10 (27.0) 48 (16.6)
Had curative treatment (e.g.
prostatectomy, radiotherapy)
147 (58.3) 14 (37.8) 161 (55.7)
Having hormone therapy 52 (20.6) 11 (29.7) 63 (21.8)
BMC Health Services Research
Page 4 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
(page number not for citation purposes)
[Consultant] said to go with the nurse and she'll
explain everything to me, which she did, and made a
good job of it ... I was with her about 20 minutes, half
an hour...to have things explained and you had the
opportunity to ask questions (38)
She was able to talk about the support services that
were available in the event of having different options
(43)
As well as playing an important role for patients immediately
post-diagnosis, specialist nurses provided ongoing
support for many patients during the course of treatment
and follow-up, through their availability for consultation
either by telephone or in person, and in some cases,
through arranging patient support groups:
I will go back and be checked from time to time and
honestly, my nurse specialist is always there and I will
require that service for some time to come (49)
The oncology nurse does run once a month in one of
the local pubs in the town a sort of a prostate get
together and has done for three or four years probably
(15)
Unique features of the specialist nurse role
Analysis of patient interviews highlighted the unique
nature of the specialist nurse role, and the value of this
role to patients. Two key features of the specialist nurse
role distinguished it from the roles of other health professionals
involved in prostate cancer care. These features
were: the availability of the specialist nurse to the patient,
and the ability of the specialist nurse to liaise between the
medical system and the patient.
The availability of the specialist nurse to the patient
Patients described the availability of the specialist nurse
firstly in terms of the amount of time the specialist nurse
was able to spend with them, and secondly in terms of the
specialist nurse's availability for contact throughout their
care.
Firstly, patients felt that the specialist nurse was able to
spend as much time with them as was needed, and that
their time with the nurse was not constrained. This was in
direct contrast with the consultant, who was seen as having
a limited consultation time. Having this time to talk
things over was particularly important for patients after
being given their diagnosis. The fact that specialist nurses
were available for as much time as the patient needed was
highly valued.
I had two, possibly, at least two meetings of hour and
a half, two hours ...discussing in detail all the possibilities,
all the options, my fears ...She did say herself,
take as long as you want, you know, I haven't booked
you down for a specific period of time and the first few
meetings did take an hour and a half, two hours.
Because I had so much to discuss with her (47)
Patients who did not see a specialist nurse after getting
their diagnosis highlighted the lack of unconstrained time
to talk things over, which had a negative emotional
impact on them.
So there I am ... fairly confirmed I would think at that
stage that I'm going to need cancer treatment, but noone
really to turn to. That was the thing, that in the
whole experience of this, that was the worst moment.
I needed somebody ...you know, in a ten minute
appointment [consultant]'d really stretched his
appointment time I'm sure to give me the benefit of
his knowledge ... But that's what I felt I needed, someone
to talk to, talk it through (14)
The timing of the consultation with the specialist nurse
was important: one patient described seeing the specialist
nurse immediately after being given the diagnosis, and
felt that this was too soon as he was still in shock following
the diagnosis.
Table 2: Characteristics of interviewed patients (n = 35)
Total number (%)
Age
55–70 13 (37.1)
70 or over 17 (48.6)up to 54 5 (14.3)
Ethnicity
South Asian 4 (11.4)
African/Caribbean 5 (14.3)White 26 (74.3)
Stage of disease/treatment
Being actively monitored without treatment 7 (20.0)
Had curative treatment (e.g. prostatectomy, radiotherapy) 17 (48.6)
Having hormone therapy 8 (22.9)Newly diagnosed (not yet treated) 3 (8.6)
BMC Health Services Research
Page 5 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
(page number not for citation purposes)
No you can't absorb it and that's in a way was one little
criticism of [specialist] nurse ... 'you've got prostate
cancer' ... and she carts you off into a tiny little cubicle
of a room ...and I don't know what the hell she said
because ...that was too soon ...I was in a, in a state of
numbness anyway at that point and so I don't really
know what it was she was trying to achieve (19)
In contrast, one patient described how the specialist nurse
had been sensitive to his shock and given him time to
come to terms with the diagnosis.
She said to me 'well whatever you are told today you're
not gonna take it all in' so they gave me a booklet on
prostate cancer and treatments, what is involved and
whatever and I was told to go away and read it, and
then if I'd got any questions or you know things like
that... (54)
A second key aspect of availability that patients valued
was the possibility of contact with the specialist nurse for
advice and support throughout their care.
Patients were often given the specialist nurse's phone
number as a point of contact if they had any concerns or
questions. This meant that contact with the specialist
nurse was easy, and could be patient-initiated, so patients
Table 3: Odds ratios for questions on patient experience of care: comparison of responses from patients who did, and did not, see a
specialist nurse
Question Saw specialist nurse
Frequency of positive
responses/total responses (%)
Did not see specialist nurse
Frequency of positive
responses/total responses (%)
Age-adjusted odds ratio
ratio, (95% confidence interval)Odds
p value
1. Given enough written or printed
information about the test results
175/225 (77.8) 14/32 (43.8) 4.58 (2.01; 10.43) p < 0.001
2. Given enough written or printed
information about active treatment
163/195 (83.6) 14/25 (56.0) 3.73 (1.46; 9.56) p = 0.01
3. Given enough written or printed
information about watchful waiting/
active monitoring
127/160 (79.4) 8/22 (36.4) 6.69 (2.45; 18.25) p < 0.001
4. Doctor or nurse clearly explained
what treatment options would
involve
210/239 (87.9) 22/36 (61.1) 3.51 (1.54; 8.01) p = 0.003
5. Doctor or nurse discussed clearly
the possible side effects or
consequences of treatment options
195/239 (81.6) 26/36 (72.2) 1.47 (0.63; 3.45) p = 0.37
6. Doctor or nurse gave an
explanation of why the other
treatment options were not suitable
136/202 (67.3) 15/30 (50) 2.05 (0.92; 4.60) p = 0.08
7. Doctor or nurse offered written
or printed information about the
treatment options
170/250 (68.0) 11/37 (29.7) 3.90 (1.76; 8.63) p = 0.001
8. Doctor or nurse offered written
or printed information about the
side effects or consequences of the
treatment options
158/252 (62.7) 10/37 (27.0) 3.81 (1.71; 8.49) p = 0.001
9. Patient made decision about
which type of treatment to have
(alone or in partnership with a
health professional)
157/251 (62.5) 11/37 (29.7) 2.69 (1.18; 6.12) p = 0.02
10. Doctor or nurse involved patient
as much as wanted in the decision
about which treatment to have
192/237 (81.0) 23/34 (67.6) 1.69 (0.73; 3.88) p = 0.22
11. After the treatment decision had
been made, doctor or nurse told
patient they could discuss their
treatment decision again
152/235 (64.7) 10/34 (29.4) 3.78 (1.68; 8.53) p = 0.001
12. Doctor or nurse told patient
that they could change their mind
about which treatment to have
132/230 (57.4) 6/33 (18.2) 4.71 (1.82; 12.22) p = 0.001
13. Doctor or nurse gave patient
enough information about sources of
help (e.g. support group/charities)
226/252 (89.7) 16/37 (43.2) 9.36 (4.11; 21.34) p < 0.001
BMC Health Services Research
Page 6 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
(page number not for citation purposes)
could have access to support or information as and when
they needed it.
It worried me to death ...my mind were in like a whirl.
I felt, I had to ring... [specialist nurse], 'cause I ask, I
was asking myself questions I couldn't answer, you
know 'Why this? And why that?'...after I spoke to her I
felt a lot better ...Oh I can ring [specialist nurse] up any
time I want to (27)
Just having the contact number was seen as a source of
reassurance, whether or not the patient actually needed to
use it.
[You can] contact her any time you want to...That's
important that you can do that. What does it do, give
you sort of reassurance that if you've got a problem or
a concern that you can ring, that you know who to ring
(38)
Patients who did not have access to this relatively quick
and responsive source of support and information had to
wait until they had an opportunity, in a scheduled consultation,
to discuss issues of concern.
Interviewer: Would you find [contact number for specialist
nurse] useful?
Patient: Yes, I would really because if um, odd times
I've passed a bit of blood from the bowel and I could
ring up and say, 'is that natural?'... You've sort of,
you've got to wait till the next appointment, which is
three months apart, and that's if they don't cancel it
again or nowt (31)
The ability of the specialist nurse to liaise between the medical
system and the patient
The second unique aspect of the specialist nurse role was
that specialist nurses were seen as being in a position to
liaise between the medical system and the patient. This
involved firstly providing or restating information about
diagnosis and treatment in terms which were clearly
understandable to the patient, and secondly, acting as an
advocate for the patient to facilitate the care process.
Firstly, patients described specialist nurses as helping
them to understand and come to terms with their diagnosis
and treatment through translating medical information
in order to present it in an understandable way. This
involved communicating in a patient-centred way and
using non-medical language. Specialist nurses were also
seen as more likely to address wider issues than simply the
diagnosis and treatment, such as the impact of treatments
on patients' lifestyles.
Patient: She did explain what the effects of the treatments
are, the hormone therapy and so on...
Wife: She was down to earth, she didn't come up with
any, you know so many medical terms...and she came
up with a lot of practical things that perhaps the consultant
wouldn't think to say... the fact that it's affecting
your lifestyle (48)
Secondly, patients described this liaison role in terms of
specialist nurses acting on their behalf to short-cut delays
in care, to gain more information for them, and even to
access particular medical services.
She can fiddle about and bang heads in the administration
and get things happening (48)
There is two specialist nurses there, I've got their numbers,
I speak to them and if there's anything else they
will speak to the consultant and then they'll get back
to me (54)
I said 'I want... [test]'...My surgeon said ' [patient
name] does not require [test]'...But she got it, she got
it through another um, consultant (49)
Where specialist nurses were involved in patient support
groups, this helped to facilitate this informal liaison role.
When we go to our [patient support] meetings if I say
to the oncology nurse ... 'well I've been a little bit worried
because...' so she says 'ok don't worry about it I'll
see Mr. so and so in the morning I'll give you a ring'
(1)
Discussion
Results from the questionnaire survey indicate that
patients who saw a specialist nurse were more likely to
have received written information and clear explanations
about their tests and treatment options, and about sources
of help and support. Patients who saw a specialist nurse
were more likely to say that they had made the treatment
decision themselves.
The qualitative findings elaborate on and help to explain
these differences. In interviews, patients described the
contribution of the specialist nurse to their experiences of
care immediately post-diagnosis, as well as over the
longer term of their treatment and monitoring for prostate
cancer. The specialist nurse was primarily seen as providing
patients with time to talk and reflect on the diagnosis,
providing advice, information and support (including
information which could support the patient in making a
treatment decision), and in some cases helping to facilitate
the course of the patient's care. When patients did not
BMC Health Services Research
Page 7 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
(page number not for citation purposes)
see a specialist nurse, they experienced gaps in their care,
in particular, a lack of time to talk things over post-diagnosis,
and a lack of immediate access to advice and support
over the course of their care.
Importantly, patients' accounts highlight the unique features
of the specialist nurse role, which make it possible
for specialist nurses to contribute to patients' positive
experiences of care. Firstly, patients described the availability
of the specialist nurse, in terms of the amount of
time the specialist nurse was able to spend with them in
contrast with other medical staff such as consultants, and
the possibility of patient-initiated contact with the specialist
nurse. This concurs with Boxhall and Dougherty's
study [15] in which patients valued the extra time available
to them with specialist nurses compared to doctors.
The second unique aspect of the specialist nurse role was
that specialist nurses were seen as being in a position to
liaise between the medical system and the patient. This
included providing or restating information about diagnosis
and treatment in terms which were clearly understandable
to the patient, and acting as an advocate for the
patient to facilitate the care process. These two key aspects
of care have been advocated as important to the specialist
nurse role [16], and this study indicates that these aspects
of the role are recognised and valued by patients
The unique nature of the specialist nurse role, with their
level of availability to the patient and their position at the
interface between the patient and the health system, was
seen as enabling specialist nurses to address specific
patient needs. Some of these needs could not be met by
professionals in different roles, as other roles do not share
the unique characteristics of the specialist nurse role (for
example, consultants are not able to offer patients their
time for unlimited periods). Taken together, the findings
of the questionnaire survey and the qualitative interviews
suggest that specialist nurses make a unique and valuable
contribution to patient experience of prostate cancer care.
There are several limitations to the work reported here
which should be noted. Firstly, the questionnaire survey
was not a randomised controlled study of an intervention,
and there is a risk of selection bias. It is possible that
patients who did and did not see a specialist nurse differed
on factors which were not measured as part of the study.
For example, patients who did not see a specialist nurse
may have felt less need for nurse input, or may have had
more or less advanced disease. This may have had an
impact on the study findings, given that only 12.8% of
participants had not seen a specialist nurse. However it is
notable that the groups did not differ in terms of treatment
type or health status. Those who did not see a specialist
nurse were older than those who did, and it is
possible that some of the participants who did not see a
specialist nurse may have been given their diagnosis prior
to the widespread input of specialist nurses in care. The
survey involved a relatively small number of patients in
three hospitals, and responders to the survey were predominantly
White British. In addition there were considerable
numbers of missing responses on some questions.
Although the response rate to the survey was relatively
high, the 40% of invited patients who did not respond to
the survey may differ systematically to those who did
respond, for example, they may be older, or have more
advanced disease. Hence the generalisability of the survey
results may be limited. The interviews reported here did
not systematically explore the role of the specialist nurse;
rather this was an issue raised spontaneously by patients,
and the analysis is limited to the issues raised by patients.
Also, the sampling frame for interviews did not aim specifically
to sample those who did and did not see a specialist
nurse. The studies do not make a distinction between
different types of specialist nurse (e.g. urology specialist
nurse and prostate cancer specialist nurse). Nevertheless,
the quantitative and qualitative components of the study
present complementary findings that together demonstrate
the benefits reported by patients of specialist nurses.
Conclusion
In conclusion, this study indicates that specialist nurses
play an important and unique role in prostate cancer care,
and have a positive impact on patient experience. It is
essential that specialist nurses are supported in their
unique role, and that their input is not threatened by
financial and organisational pressures.
Competing interests
The author(s) declare that they have no competing interests.
Authors' contributions
The authors contributed to the article as follows: CT, PS
and RB designed the study. CT, PS and SA collected the
data. CT analysed the data with input from PS, SA and RB.
CT drew up the draft manuscript and PS, SA and RB contributed
to producing the final version.
Acknowledgements
The study was funded by the NHS Service Delivery and Organisation
National R&D Programme (SDO/77/2004). We would like to thank the
men, and their carers, who participated in this research, and the members
of staff at participating hospitals who helped with recruitment. We would
also like to thank Raj Gill for transcribing the patient interviews.
References
1. National Audit Office: Tackling Cancer: Improving the Patient Journey
London: House of Commons; 2005.
2. The Prostate Cancer Charity Specialist Nurse Programme
[http://www.prostate-cancer.org.uk/what/nurses.asp]
3. McIntosh J:
the clinical nurse specialist and nurse consultant role. Evaluating the evidence for further investment inNew
Publish with
scientist can read your work free of chargeBioMed Central and every
"BioMed Central will be the most significant development for
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Health Services Research
Page 8 of 82008, 8:65 http://www.biomedcentral.com/1472-6963/8/65
(page number not for citation purposes)
Nursing Roles: Deciding the future for Scotland. Role Development Consensus
Conference: 17 & 18 November 2003. Edinburgh
4. Davies M, Dixon S, Currie CJ, Davis RE, Peters JR:
hospital diabetes specialist nursing service: a randomised
controlled trial.
5. Forbes A, While A, Mathes L, Griffiths P:
nurse programme.
6. National Institute for Clinical Excellence:
Improving Outcomes in Urological Cancers. The Manual. London
7.
www.prostatecharter.org.uk/about_charter.php]
8. Hill A: 2003:18-22.Evaluation of aDiabet Med 2001, 18:301-307.Evaluation of a MS specialistInt J Nurs Stud 2006, 43(8):985-1000.Guidance on Cancer Services:2002.The Prostate Cancer Charter for Action 2005 [http://Financial threat to CNSs. Cancer Nursing Practice 2006,
5(7):
9. Harrison S:
balance their books: some NHS trusts that are in deficit are
targeting their most expensive nurses, but are they making
matters worse?
10. Norton C, Porrett T:
Nursing
11. Neate J:
National Prostate Conference. 3rd November 2006. London
www.prostate-cancer.org.uk/docs/conference_06/speech_john.doc].
12. Richardson A:
Prostate Cancer Charity Specialist Nurse Programme.
Prostate Cancer Charity National Prostate Conference. 3rd November
2006. London
what/conference06/downloads/
Specialist_Prostate_Cancer_Nurses_-_Prof_Alison_Richardson.ppt].
13. Baker R, Sinfield P, Agarwal S, Tarrant C, Mellon JK, Steward W, Colman
A, Kockelbergh R, Sproston K:
Measures of the Patient Experience. Report for the National Co-ordinating
Centre for NHS Service Delivery and Organisation R&D
2007.
14. Ritchie J, Spencer L:
research.
RG. London: Routledge; 1994:173-194.
15. Boxhall S, Dougherty M:
role for men with prostate cancer.
16. The London and South East Lung Cancer Forum for Nurses:
on the role of the specialist nurse in supporting patients
with lung cancer. 12-13.The tide has turned for specialists as trusts try toNurs Stand 2006, 20(39):14-17.The state of GI nursing. Gastrointestinal2006, 4(7):8-9.The challenges of innovation. The Prostate Cancer Charity2006 [http://Findings from a Multi Method Evaluation of theThe2006 [http://www.prostate-cancer.org.uk/content/Prostate Cancer Care: ImprovingLondon: NCCSDO;Qualitative data analysis for applied policyIn Analysing Qualitative Data Edited by: Bryman A, BurgessAn evaluation of a specialist nursingUrol Nurs 2003, 23:148-152.GuidelinesEur J Cancer Care 2004, 13:344-348.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6963/8/65/prepub